RecruitingNot ApplicableNCT03875716

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

A Phase 2 Study of De-Intensified Risk-Adapted Postoperative Radiation Therapy for Human Papilloma Virus Associated Oropharyngeal Squamous Cell Carcinoma: the ADAPT Trial


Sponsor

Dana-Farber Cancer Institute

Enrollment

111 participants

Start Date

May 20, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

This research study is studying lowering the standard dose of radiation and chemotherapy after surgery, to minimize the side effects and improve the quality of life.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring whether the radiation dose given after surgery for HPV-related throat cancer (tonsil or base of tongue cancer) can be safely reduced. Because HPV-positive throat cancers respond very well to treatment, researchers want to test if a lower, gentler radiation dose is just as effective while producing fewer side effects. **You may be eligible if...** - You have been diagnosed with squamous cell cancer of the tonsil or base of tongue that is HPV-positive (confirmed by p16 staining or other tests) - Your surgery was performed at Brigham and Women's Hospital - Your surgeon expects to remove the tumor completely with clear margins - You are 18 or older in good general health **You may NOT be eligible if...** - Your tumor is HPV-negative - You have had prior radiation to the head or neck - You are pregnant - Your organ function does not meet required thresholds - You have serious medical conditions making surgery or radiation unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONRadiation therapy

Radiation therapy


Locations(1)

Dana Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03875716


Related Trials